The development of biopharmaceuticals is expanding at an unprecedented rate, as the industry now comprises around 20 percent of the global pharmaceutical marke...

Viral vectors are a crucial tool within the advanced therapy sector, providing an elegant solution for gene delivery in areas such as gene therapy and vaccine develo...

Developing drug-device combination products for rare diseases presents unique challenges and opportunities for biopharmaceutical companies. These advanced drug deliv...

Complex biologics and next-generation cell and gene therapies demand precision handling to maintain stability and promote optimised and patient centric clinical tria...

Over the past few months, I’ve had numerous conversations at work and conferences about particulates in cell and gene therapies. These discussions have highlighted t...

Cell and gene therapies (C&GTs) are revolutionising medicine, offering the tantalising prospect of cures for diseases once considered incurable. This remarkable ...

The rise of cell and gene therapy (CGT) is revolutionising how we treat complex diseases, offering life-changing treatments for patients in need. However, with these...

Frustration, exhaustion, and a sense of being overwhelmed – these are the hallmarks of “portal fatigue”, a growing problem for approved treatment center (ATC) staff ...

In the world of modern manufacturing and production, staying at the forefront of technology is not just an advantage; it's a necessity. Mabtech understands this well...

Children with medical complexity (CMC) live with congenital or acquired multi-system diseases, severe neurologic conditions with marked functional impairment, and/or...